attachment
attachment
attachment
attachment

My sister had allergic bronchitis

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here is a clear breakdown of all four inhalers prescribed to your sister:

Your Sister's Inhalers - What Each One Does

1. Foracort 400 - Formoterol Fumarate + Budesonide (Cipla)

  • Type: Long-Acting Beta-2 Agonist (LABA) + Inhaled Corticosteroid (ICS) - combination
  • How it works: Formoterol relaxes and opens the airways (bronchodilator), while Budesonide is a steroid that reduces airway inflammation and swelling
  • Used for: Maintenance (daily) control of asthma and COPD. The "400" refers to 400 mcg of budesonide per dose, making this a medium-to-high strength controller
  • When to use: Regular daily doses as prescribed - this is a preventer, not a rescue inhaler. As noted in Goldman-Cecil Medicine, budesonide-formoterol combination is also approved as "as-needed" therapy in some countries

2. Saliprair L 20 - Levosalbutamol + Ipratropium Bromide (50+20 mcg/actuation)

  • Type: Short-Acting Beta-2 Agonist (SABA) + Short-Acting Muscarinic Antagonist (SAMA) - combination
  • How it works: Levosalbutamol (the active form of salbutamol) rapidly opens the airways; Ipratropium blocks the nerve signals that cause airway constriction and excess mucus
  • Used for: Acute relief of bronchospasm - this is a rescue inhaler for when symptoms flare up (wheeze, breathlessness, chest tightness)
  • When to use: When she feels breathless or has an attack. CFC-free HFA formulation

3. OVR-9 (Precept) - Tiotropium Bromide 9 mcg

  • Type: Long-Acting Muscarinic Antagonist (LAMA) - once-daily anticholinergic
  • How it works: Blocks muscarinic (M3) receptors in the airways for 24 hours, keeping the airways open all day and reducing mucus secretion
  • Used for: Once-daily maintenance bronchodilation. Primarily a COPD drug, but also used in severe or uncontrolled asthma as add-on therapy. Goodman & Gilman's Pharmacological Basis confirms tiotropium is now used in severe asthma management in addition to COPD
  • When to use: Once daily, every morning - long-term controller

4. Precept-S 250 - Fluticasone Propionate + Salmeterol 250 mcg

  • Type: ICS (Inhaled Corticosteroid) + LABA (Long-Acting Beta-2 Agonist) - combination (same class as Foracort but different molecules)
  • How it works: Fluticasone is a potent anti-inflammatory steroid; Salmeterol is a long-acting bronchodilator (12-hour duration)
  • Used for: Maintenance control of asthma. This is equivalent to Advair/Seretide internationally
  • When to use: Twice daily as a regular controller inhaler

Summary Table

InhalerDrug(s)ClassPurposeFrequency
Foracort 400Formoterol + BudesonideLABA + ICSControllerTwice daily
Saliprair L 20Levosalbutamol + IpratropiumSABA + SAMARescue (reliever)As needed
OVR-9Tiotropium 9 mcgLAMAControllerOnce daily
Precept-S 250Fluticasone + SalmeterolICS + LABAControllerTwice daily

Important Notes

  • Your sister has 3 controller inhalers and 1 rescue inhaler - this suggests she has moderate-to-severe allergic bronchitis/asthma requiring step-up therapy
  • The Saliprair L 20 (rescue inhaler) should only be used for sudden symptoms, not regularly
  • Foracort and Precept-S both contain an ICS + LABA - the doctor has prescribed two such inhalers, which may be a step-up strategy or a transition plan. Make sure she follows her doctor's instructions on whether to use both or just one
  • All inhalers are Rx (prescription) medications - she should not stop or change doses without consulting her doctor
  • Proper inhaler technique is important for the medicines to reach the lungs effectively
If she is unsure which inhaler to use when, please consult the prescribing doctor for a clear written action plan.
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Her PFT

Finding Sources
Finding Sources
Here is a full, plain-language interpretation of your sister's PFT report.

Patient Details

  • Name: Maloth Thanuja | Age: 29 years | Sex: Female
  • Height: 155 cm | Weight: 48 kg | Smoker: No
  • Date: 16/07/2026

Key Values - What the Numbers Say

ParameterPredictedMeasured (Pre)% of PredictedWhat it means
FVC2.35 L1.20 L51%Total air she can blow out - severely reduced
FEV11.90 L0.64 L34% (approx)Air in first second - severely reduced
FEV1/FVC%80.9953.37Ratio is LOW = obstruction confirmed
FEV3/FVC%97.0093.20115Near normal at 3 sec
PEFR6.281.6326%Peak expiratory flow - severely reduced
FEF 25-752.851.3849%Mid-flow = small airway obstruction
FEF 75-85--0.83--Very low - severe small airway narrowing
FEV5--1.63--Still low at 5 seconds
MVV105.7811.9011%Maximum breathing capacity - severely impaired
Lung Age29 yrs40 yrs138%Her lungs function like a 40-year-old

Official Report Findings

Pre-Medication Report:

  • Early Small Airway Obstruction is present
  • Spirometry shows Moderate Restriction (FVC% < 65)
  • FEV1/FVC% > 70 (it is 53, which actually means obstruction is present - the machine flagged the restrictive FVC pattern)

Final Interpretation (handwritten):

"Mixed Obstructive and Restrictive Disorder - Correlate Clinically"
  • COPD Severity post-bronchodilator: Restrictive pattern noted

What "Mixed Obstruction + Restriction" Means

Her lungs have two problems happening together:
1. Obstructive component (FEV1/FVC = 53%, which is below the normal cutoff of 70%)
  • The airways are narrowed (bronchospasm, mucus, inflammation)
  • Air flows out slowly and incompletely
  • This is consistent with her allergic bronchitis / asthma
2. Restrictive component (FVC = 51% of predicted, severely reduced)
  • The total volume of air she can move is also reduced
  • This means her lungs cannot fully expand
  • In the context of asthma without smoking history, this likely reflects air trapping (gas gets trapped behind blocked small airways, reducing the usable lung volume), or a co-existing condition like chest wall stiffness
MVV = only 11% of predicted (11.90 L/min vs predicted 105.78 L/min) - this is the most striking finding. Her maximal breathing capacity is severely reduced, indicating significant breathing work impairment.

Severity Assessment

DomainSeverity
Airflow obstructionModerate-to-Severe (FEV1/FVC 53%)
Lung volume (FVC)Severe restriction (51% predicted)
Peak flowSevere (26% predicted)
Overall functional lung age40 years (vs actual age 29)

What This Means for Her Treatment

This PFT result explains and justifies why her doctor prescribed 4 inhalers:
  • The severe mixed pattern means she needs both an anti-inflammatory (steroid) and multiple bronchodilators working together
  • The tiotropium (OVR-9) in particular makes sense here - it helps keep airways open 24 hours and is especially useful when both obstruction and restriction are present
  • The low MVV (11%) suggests she may feel very breathless with even light activity
The report recommends clinical correlation - meaning her doctor needs to review these numbers in context with her symptoms, examination, and response to inhalers.

⚠️ Important: These values are pre-bronchodilator. Post-bronchodilator values are missing (marked "--") which means either the test was not done with bronchodilator, or results were not recorded. A post-bronchodilator test would tell the doctor how much of the obstruction is reversible with her inhalers. Please ask her doctor about this, as it is important for adjusting treatment.
This is a shared conversation. Sign in to Orris to start your own chat.